Corundum Group, Inc. Pfizer Inc Transaction History
Corundum Group, Inc.
- $218 Million
- Q3 2024
A detailed history of Corundum Group, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Corundum Group, Inc. holds 42,741 shares of PFE stock, worth $1.2 Million. This represents 0.57% of its overall portfolio holdings.
Number of Shares
42,741
Previous 53,561
20.2%
Holding current value
$1.2 Million
Previous $1.5 Million
17.49%
% of portfolio
0.57%
Previous 0.59%
Shares
32 transactions
Others Institutions Holding PFE
# of Institutions
3,240Shares Held
3.72BCall Options Held
73.2MPut Options Held
108M-
Vanguard Group Inc Valley Forge, PA511MShares$14.4 Billion0.28% of portfolio
-
Black Rock Inc. New York, NY424MShares$11.9 Billion0.27% of portfolio
-
State Street Corp Boston, MA287MShares$8.06 Billion0.36% of portfolio
-
Wellington Management Group LLP Boston, MA166MShares$4.67 Billion0.85% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA117MShares$3.29 Billion0.63% of portfolio
About PFIZER INC
- Ticker PFE
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 5,612,349,952
- Market Cap $158B
- Description
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...